OKUR: Saccomano Nicholas A discloses a sale

By AlphaYouPublished Sep 23, 2026Form 4

Stocks in this disclosure

Reported activity

Saccomano Nicholas A

Reporting filer

Saccomano Nicholas A reported Sale in OnKure Therapeutics, Inc.: 87 units of Class A Common Stock, dated 2026-09-21. The full Form 4 contains 1 transaction entry.

Disclosed: Sep 23, 2026

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Class A Common Stock	Saccomano Nicholas A	2026-09-21	S	Sale	87	2.9742	11,160	2 days	Filed terms security Title: Class A Common Stock transaction Date: 2026-09-21 transaction Form Type: 4 transaction Code: S equity Swap Involved: 0 id: F1 transaction Shares: 87 transaction Price Per Share: 2.9742 id: F2 transaction Acquired Disposed Code: D shares Owned Following Transaction: 11160 id: F3 direct Or Indirect Ownership: D nature Of Ownership:

Class A Common Stock

Owner: Saccomano Nicholas A
Date: 2026-09-21
Code: S
Action: Sale
Quantity: 87
Price: 2.9742
Following holdings: 11,160
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Class A Common Stock
transaction Date: 2026-09-21
transaction Form Type: 4
transaction Code: S
equity Swap Involved: 0
id: F1
transaction Shares: 87
transaction Price Per Share: 2.9742
id: F2
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 11160
id: F3
direct Or Indirect Ownership: D
nature Of Ownership:

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Saccomano Nicholas A: President and CEO, Director.
F1: These shares were automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"), pursuant to the terms of the Issuer's 2023 RSU Equity Incentive Plan.
F2: This transaction was executed in multiple trades at prices ranging from $2.95 to $3.06. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3: Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

Class A Common Stock

Saccomano Nicholas A

2026-09-21

Sale

2.9742

11,160

2 days

Filed terms

security Title: Class A Common Stock
transaction Date: 2026-09-21
transaction Form Type: 4
transaction Code: S
equity Swap Involved: 0
id: F1
transaction Shares: 87
transaction Price Per Share: 2.9742
id: F2
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 11160
id: F3
direct Or Indirect Ownership: D
nature Of Ownership:

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

Saccomano Nicholas A: President and CEO, Director.

F1: These shares were automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"), pursuant to the terms of the Issuer's 2023 RSU Equity Incentive Plan.

F2: This transaction was executed in multiple trades at prices ranging from $2.95 to $3.06. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3: Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU.